Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current clinical concepts in perioperative anticoagulation.

R L Hewitt1, K L Chun, L M Flint

  • 1Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

The American Surgeon
|March 13, 1999
PubMed
Summary

Perioperative management for patients at high risk of thromboembolism involves balancing bleeding and clotting risks. Low molecular weight heparin offers safety and efficiency advantages over unfractionated heparin for these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporary monocular blindness associated with acute carotid thrombosis: a case report.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2001
Same author

Noncompliance of health care workers with universal precautions during trauma resuscitations.

Southern medical journal·2001
Same author

Higher risk of HIV transmission during trauma resuscitations.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society·2000
Same author

Evolution in the management of hepatic trauma: a 25-year perspective.

Annals of surgery·2000
Same author

A critical assessment of endpoints of shock resuscitation.

The Surgical clinics of North America·2000
Same author

Post-treatment dopexamine infusions partially reverse reductions in cranial mesenteric blood flow and mucosal oxygenation induced by hypoxia in newborn piglets.

The American surgeon·1999

Area of Science:

  • Cardiology
  • Hematology
  • Surgical Management

Background:

  • Perioperative management of patients with thromboembolism risks requires balancing anticoagulation therapy risks against thromboembolic event risks.
  • Warfarin therapy discontinuation for surgery creates a subtherapeutic international normalized ratio (INR) interval, increasing risk for patients with venous thromboembolism, nonvalvular atrial fibrillation, or mechanical heart valves.

Purpose of the Study:

  • To evaluate the perioperative management strategies for patients at significant risk for thromboembolism.
  • To assess the risks and benefits of anticoagulant therapy, including heparin and warfarin, during the perioperative period.

Main Methods:

  • Review of current literature and clinical guidelines on perioperative anticoagulation management.
  • Analysis of risk stratification for thromboembolic events and bleeding complications associated with different anticoagulant regimens.

Related Experiment Videos

  • Comparison of intravenous unfractionated heparin versus low molecular weight heparin in perioperative settings.

    • Main Results:

    • Intravenous heparin is justified preoperatively and postoperatively for acute venous thromboembolic events within the past month.
    • Postoperative intravenous heparin may be justified for events within 2-3 months, but not typically for events over 3 months due to low recurrence risk.
    • Intravenous heparin is generally not recommended for arterial embolism risks in nonvalvular atrial fibrillation or mechanical heart valve patients during the subtherapeutic INR interval.
    • Deferring elective surgery for over a month may be advisable after a recent arterial embolism event.
    • Low molecular weight heparin demonstrates safety and efficiency advantages over unfractionated intravenous heparin.

    Conclusions:

    • Perioperative anticoagulation management should be individualized based on the specific thromboembolic risk and timing of the event.
    • Low molecular weight heparin represents a potentially safer and more efficient alternative to unfractionated heparin for managing perioperative thromboembolism risks.
    • Further research and clinical experience with low molecular weight heparin may lead to refined management protocols.